Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-19-000182

SVP, GC and Corporate Affairs gave up 2,012 shares (to pay taxes)

  • SVP, GC and Corporate Affairs acquired 6,787 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Shawnte SVP, GC and Corporate Affairs 2019-03-01 Option exercise +6,787 82,539 D
Mitchell Shawnte SVP, GC and Corporate Affairs 2019-03-01 Shares withheld for taxes −2,012 $1.57 $3,159 80,527 D
Derivatives
Mitchell Shawnte SVP, GC and Corporate Affairs 2019-02-28 Grant or award · Stock Option (right to buy) +67,400 67,400 D
Mitchell Shawnte SVP, GC and Corporate Affairs 2019-03-01 Option exercise · Restricted Stock Unit −6,787 0 D
Loading xslF345X03/mitchell.xml…